Rapid thickening of aminosilicones to promote emulsion stability and adhesion of UV-curable quantum dot enhancement film emulsions
US-12122948-B2 · Oct 22, 2024 · US
US9133394B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9133394-B2 |
| Application number | US-201414208079-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 13, 2014 |
| Priority date | Mar 14, 2013 |
| Publication date | Sep 15, 2015 |
| Grant date | Sep 15, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Quantum-dot binding ligands with silsesquioxane moieties are provided. The quantum-dot binding ligands include a multiplicity of amine or carboxy binding ligands in combination with silsesquioxane moieties providing improved stability for the ligated quantum dots. The ligands and coated nanostructures of the present invention are useful for close packed nanostructure compositions, which can have improved quantum confinement and/or reduced cross-talk between nanostructures.
Opening claim text (preview).
What is claimed is: 1. A quantum dot binding-ligand having a structure according to Formula I wherein: A is a polyhedral oligomeric silsesquioxane (POSS) moiety comprising 6 to 12 silicon atoms; each group —O—Si(R 1 ) 2 -L-(R 2 ) q is bound to a silicon atom in the POSS moiety; each R 1 is independently selected from the group consisting of H and C 1-6 alkyl; each L is independently selected from the group consisting of C 3-8 alkylene, C 3-8 heteroalkylene, and C 3-8 alkylene-(C(O)NH—C 2-8 alkylene) q ; each R 2 is independently selected from the group consisting of C(O)OH and NR 2a R 2b , wherein R 2a and R 2b are each independently selected from the group consisting of H and C 1-6 alkyl; each R 3 is independently selected from the group consisting of C 8-20 alkyl, C 8-20 heteroalkyl, C 8-20 alkenyl, C 8-20 alkynyl, cycloalkyl, and aryl; the subscript m is an integer from 1 to 20; the subscript n is an integer from 1 to 20; and each subscript q is independently an integer from 2 to 10. 2. The quantum dot binding-ligand according to claim 1 , wherein each R 1 is independently C 1-3 alkyl. 3. The quantum dot binding-ligand according to claim 1 , wherein each R 1 is methyl. 4. The quantum dot binding-ligand according to claim 1 , wherein each -L-(R 2 ) q group is independently selected from the group consisting of C 3-8 alkylene-(R 2 ) 2 , and C 3-8 alkylene-(C(O)NH—C 2-8 alkylene-(R 2 ) 2 . 5. The quantum dot binding-ligand according to claim 1 , wherein each -L-(R 2 ) q group is independently selected from the group consisting of: 6. The quantum dot binding-ligand according to claim 1 , wherein each R 2 is C(O)OH. 7. The quantum dot binding-ligand according to claim 6 , wherein each L is C 3-8 alkylene. 8. The quantum dot binding-ligand according to claim 6 , wherein each -L-(R 2 ) q group is: 9. The quantum dot binding-ligand according to claim 1 , wherein each R 2 is NH 2 . 10. The quantum dot binding-ligand according to claim 9 , wherein each L is independently C 3-8 alkylene-(C(O)NH—C 2-8 alkylene) q ; and each subscript q is 2. 11. The quantum dot binding-ligand according to claim 10 , wherein each -L-(R 2 ) q group is: 12. The quantum dot binding-ligand according to claim 1 , wherein each R 3 is independently selected from the group consisting of octyl, isooctyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, icosyl, cyclopentyl, cyclohexyl, cyclooctyl, norbornyl, adamantyl, phenyl, naphthyl, and anthracenyl. 13. The quantum dot binding-ligand according to claim 1 , wherein R 3 is selected from the group consisting of cyclohexyl, phenyl, and isooctyl. 14. The quantum dot binding-ligand according to claim 1 , wherein the subscript m is an integer from 5 to 10. 15. The quantum dot binding-ligand according to claim 1 , wherein the subscript m is 7. 16. The quantum dot binding-ligand according to claim 1 , wherein the subscript n is an integer from 1 to 6. 17. The quantum dot binding-ligand according to claim 1 , wherein the subscript n is 3. 18. The quantum dot binding-ligand according to claim 1 , wherein the POSS moiety has the following structure: 19. The quantum dot binding-ligand according to claim 18 , wherein: each R 1 is methyl; each -L-(R 2 ) q group is selected from the group consisting of: each R 3 is selected from the group consisting of cyclohexyl, phenyl, and isooctyl; the subscript m is 7; and the subscript n is 3. 20. A composition comprising: a quantum dot binding-ligand of claim 1 ; and a first population of light emitting quantum dots (QDs).
with zinc or cadmium · CPC title
non-luminescent particle coatings or suspension media · CPC title
Polysiloxanes modified by chemical after-treatment · CPC title
containing silicon bound to oxygen-containing groups · CPC title
nitrogen-containing groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.